Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering ...
Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring.
Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.
A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...
J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.
ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...
Pfizer Inc. has announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination ...
Pfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon (NYSE:HLN) to lower its stake in ...